INFECTIOUS ETIOLOGY TESTICULAR CANCER

传染性病因睾丸癌

• 批准号: 6173940
• 负责人: LOREN LIPWORTH
• 金额: $ 6.91万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-09-02 至 2002-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6173940
• 关键词: Chlamydia trachomatis; Scandinavian country; age difference; antibody titering; cancer registry /resource; cancer risk; clinical research; disease /disorder etiology; enzyme linked immunosorbent assay; herpes simplex virus 2; human data; human herpesvirus 8; human papillomavirus; human tissue; immunofluorescence technique; infection related neoplasm /cancer; male; mathematical model; neoplasm /cancer diagnosis; neoplasm /cancer epidemiology; serum; sexually transmitted diseases; testis neoplasms

The trend of increasing testicular cancer incidence is unlikely to be explained by known risk factors such as cryptorchidism. An infectious etiology of testicular cancer has been proposed, based on similarities between the age-specific incidence pattern of testicular cancer and that of other virus-associated malignancies. Only a small number of epidemiologic studies have evaluated this hypothesis, but collective results suggest that exposure to EBV and CMV may relate to testicular cancer risk. Further indirect evidence comes from studies showing increased risk among immunocompromised men, as well as from studies indicating a relation between testicular cancer and history of sexually transmitted diseases. Direct epidemiologic evidence regarding the role of sexually transmitted infectious agents in testicular cancer etiology is limited although suggestive. Using serum collected prospectively, we propose to evaluate the association between antibody response to HSV-2, HPV-16 and 15, HHV-8 and Chlamydia trachomatis on the one hand and the occurrence of testicular cancer on the other. As a secondary aim, we will examine whether the associations between infection with any of these agents and testicular cancer are modified by age. The proposed study is a case-control study nested in a well-defined cohort of men who donated blood samples as part of the JANUS project in Norway. The JANUS project, sponsored by the Norwegian Cancer Society, was established in 1973 for the purpose of prospectively collecting serum to be used in epidemiologic studies of cancer development and cardiovascular disease. As of October 1993, the JANUS serum bank contained 424,938 serum samples from 293,692 individuals, none of whom had cancer at the time of blood sampling. All blood donors to the JANUS serum bank are annually linked, through a unique, individual identification number, with the Cancer Registry of Norway. Eligible cases for the present analysis are male blood donors listed in the Cancer Registry through 1993 with a diagnosis of invasive testicular cancer. For each case, three blood donors, individually matched by age and year at sample collection, have been randomly selected from the JANUS serum bank as controls. A total of 88 case patients and 262 matched controls have been identified and will be included in the proposed analysis. Serum antibody titers against HSV-2, HPV, HHV-8 and C. trachomatis will be determined using enzyme-linked immunosorbent and immunofluorescence assays. Individual antibody titer values will be distributed into quartiles based on the distribution of the entire study population. The data will be modeled through conditional logistic regression, taking into account the individual matching. The JANUS cohort provides a unique opportunity to study infectious agents in relation to testicular cancer risk. To our knowledge, this is the first study to evaluate the viral origin of testicular cancer using serum collected prior to diagnosis.

睾丸癌发病率上升的趋势不太可能用隐睾等已知的危险因素来解释。基于睾丸癌的年龄特异性发病率模式与其他病毒相关恶性肿瘤之间的相似性，已经提出了睾丸癌的感染性病因。只有少数流行病学研究评估了这一假设，但总体结果表明，暴露于eb病毒和巨细胞病毒可能与睾丸癌风险有关。进一步的间接证据来自研究，表明免疫功能低下的男子患癌风险增加，以及表明睾丸癌与性传播疾病史之间存在关系的研究。关于性传播感染因子在睾丸癌病因学中的作用的直接流行病学证据虽然具有启发性，但有限。我们拟采用前瞻性采集的血清，评价对HSV-2、HPV-16和15、HHV-8和沙眼衣原体的抗体反应与睾丸癌发生的关系。作为次要目的，我们将研究感染任何这些药物和睾丸癌之间的关联是否会随着年龄而改变。拟议的研究是一项病例对照研究，研究对象是挪威JANUS项目中捐献血液样本的一组明确定义的男性。由挪威癌症协会赞助的JANUS项目成立于1973年，目的是前瞻性地收集血清，用于癌症发展和心血管疾病的流行病学研究。截至1993年10月，JANUS血清库包含来自293,692个人的424,938份血清样本，在血液取样时没有人患有癌症。JANUS血清库的所有献血者每年都通过一个独特的个人识别号码与挪威癌症登记处联系起来。符合本分析的病例是1993年癌症登记处列出的诊断为浸润性睾丸癌的男性献血者。对于每个病例，从JANUS血清库中随机选择三名献血者作为对照，分别按年龄和样本收集年份进行匹配。共确定了88例患者和262例匹配对照，并将纳入拟议的分析。针对HSV-2、HPV、HHV-8和沙眼衣原体的血清抗体滴度将采用酶联免疫吸附法和免疫荧光法测定。个体抗体滴度值将根据整个研究人群的分布分布成四分位数。考虑到个体匹配，数据将通过条件逻辑回归建模。JANUS队列提供了一个独特的机会来研究与睾丸癌风险相关的感染因子。据我们所知，这是第一个利用诊断前收集的血清来评估睾丸癌病毒起源的研究。